Mitoxantrone Hydrochloride
CAS 70476-82-3 2 API suppliersSmall Molecule
Overview
Mitoxantrone Hydrochloride is a synthetic antineoplastic agent used in the treatment of certain types of cancer and multiple sclerosis. It works by intercalating into DNA, disrupting replication and transcription processes.
API suppliers (2)
Suppliers of Mitoxantrone Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
Where these suppliers are
China1USA1
- CHONGQING CARELIFE PHARMACEUTICAL CO LTDChina1 active DMF
- Cipla USA, Inc.USA
Therapeutic areas
OncologyMultiple Sclerosis
Verified Supplier Partner
Do you supply Mitoxantrone Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.